Disclosure Of Fair Value Measurement [Text Block]

Biotest AG - Filing #6464577

Concept As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
2024-01-01 to
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
Disclosure of fair value measurement [text block]
Disclosure of fair value measurement of assets [text block]
Disclosure of fair value measurement of assets [abstract]
Disclosure of fair value measurement of assets [line items]
Assets
1,434,000 EUR
1,410,900 EUR
Reconciliation of changes in fair value measurement, assets [abstract]
Disclosure of fair value measurement of liabilities [text block]
Disclosure of fair value measurement of liabilities [abstract]
Disclosure of fair value measurement of liabilities [line items]
Liabilities
9,033,000,000 EUR
9,120,000,000 EUR
Reconciliation of changes in fair value measurement, liabilities [abstract]
Disclosure of fair value measurement of equity [text block]
Disclosure of fair value measurement of equity [abstract]
Disclosure of fair value measurement of equity [line items]
Equity
2,745,000,000 EUR
2,198,000,000 EUR
396,000,000 EUR
53,000,000 EUR
5,307,000,000 EUR
85,000,000 EUR
115,000,000 EUR
4,989,000,000 EUR
2,498,000,000 EUR
2,198,000,000 EUR
11,000,000 EUR
396,000,000 EUR
3,711,000,000 EUR
95,000,000 EUR
2,198,000,000 EUR
1,232,000,000 EUR
396,000,000 EUR
20,000,000 EUR
Reconciliation of changes in fair value measurement, entity's own equity instruments [abstract]

Talk to a Data Expert

Have a question? We'll get back to you promptly.